Cargando…
Doxorubicin Dose Deintensification in Pediatric Osteosarcoma, Is Less Better?
Introduction We implemented new clinical practice guidelines (CPG) for patients with osteosarcoma starting in January 2009. These guidelines were based on standard European and American Osteosarcoma Study regimen, which includes six cycles of doxorubicin with a cumulative dose of 450 mg/m (2) . Aim...
Autores principales: | Halalsheh, Hadeel, Abu-Hijlih, Ramiz, Ismael, Taleb, Shehadeh, Ahmad, Salaymeh, K. J., Boheisi, Mohammad, Sultan, Iyad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691917/ https://www.ncbi.nlm.nih.gov/pubmed/38047045 http://dx.doi.org/10.1055/s-0042-1760203 |
Ejemplares similares
-
Factors associated with antihypertensive treatment intensification and deintensification in older outpatients
por: Aubert, Carole E., et al.
Publicado: (2021) -
Radiation Therapy for Prostate Cancer: Challenges Facing Low-Middle Income Countries During COVID Pandemic
por: Abu-Hijlih, Ramiz, et al.
Publicado: (2022) -
Deintensification Strategies Using Proton Beam Therapy for HPV-Related Oropharyngeal Cancer
por: Gamez, Mauricio E., et al.
Publicado: (2021) -
Current Evidence of a Deintensification Strategy for Patients with HPV-Related Oropharyngeal Cancer
por: Sung, Soo-Yoon, et al.
Publicado: (2022) -
Glycemic treatment deintensification practices in nursing home residents with type 2 diabetes
por: Lederle, Lauren I., et al.
Publicado: (2022)